Hi! I'm Colby...

01
About Me

I'm Colby T. Ford, Ph.D.

I'm a Cloud Genomics and AI Architect. I have a passion for Mathematics and Bioinformatics research. So, I use Machine Learning and Cloud Computing to help along the way.

I am the founder of <Tuple>, a genomic-focused Microsoft and Databricks partner consulting firm, and the co-founder of Amissa, a digital health company focused on the use of wearable devices in the study of neurological diseases. Also, I currently work for Seagen, a biotech company working to develop antibody-based treatments in oncology.

Originally from Lenoir, North Carolina, I studied Applied Mathematics, Data Science, and Computational Biology at the University of North Carolina at Charlotte. I am currently based in Charlotte, North Carolina.


  • Connect:
02
Skills
  • Mathematics

    Statistical Modeling
    Bayesian Nets
    Operations Research
    Numerical Logic

  • Machine Learning

    Algorithm Design
    Natural Language Processing
    Deep Learning
    Artificial Intelligence

  • Computational Biology

    Human Genomics
    Phylogenetics
    Molecular Sequence Analysis
    Infectious Diseases

  • Distributed Computing

    Apache Spark (Databricks)
    Cluster Computing (MPI/SNOW)
    GPU-Based Processing (CUDA)
    High Performance Computing

  • Programming

    R/SparkR
    Python/PySpark
    SQL
    Visual Basic

  • Web and Design

    HTML5+CSS
    LaTeX
    API Development
    Visualization

03
Research
  • Genomics, SARS-CoV-2, Machine Learning

    SARS-CoV-2 XBB.1.5 RBD-Antibody Predictions

    Predicting changes in neutralizing antibody activity for SARS-CoV-2 XBB.1.5 using in silico protein modeling..

    The SARS-CoV-2 variant XBB.1.5 is of concern as it has high transmissibility. XBB.1.5 currently accounts for upwards of 30% of new infections in the United States. One year after our group published the predicted structure of the Omicron (B.1.1.529) variant's receptor binding domain and antibody binding affinity, we return to investigate the new mutations seen in XBB.1.5 which is a descendant of Omicron. Using in silico modeling approaches against newer neutralizing antibodies that are shown effective against B.1.1.529, we posit the immune consequences of XBB.1.5's mutations and show that there is no statistically significant difference in overall antibody evasion when comparing to the B.1.1.529 and other related variants (e.g. BJ.1 and BM.1.1.1). However, noticeable changes in neutralizing activity were seen due to specific amino acid changes of interest in the newer variants.

  • Genomics, Cloud, Machine Learning

    Genomics in the Azure Cloud Book

    Building a cloud genomics architecture in Azure using enterprise-grade platform services.

    This practical guide bridges the gap between general cloud computing architecture in Microsoft Azure and scientific computing for bioinformatics and genomics. You'll get a solid understanding of the architecture patterns and services that are offered in Azure and how they might be used in your bioinformatics practice. You'll get code examples that you can reuse for your specific needs. And you'll get plenty of concrete examples to illustrate how a given service is used in a bioinformatics context.

  • Genomics, SARS-CoV-2, Machine Learning

    SARS-CoV-2 Omicron RBD Predictions

    Deep learning-based predictions of the SARS-CoV-2 Omicron (B.1.1.529) variant receptor binding domain with neutralizing antibodies.

    The genome of the SARS-CoV-2 Omicron variant (B.1.1.529) was released on November 22, 2021, which has caused a flurry of media attention due the large number of mutations it contains. These raw data have spurred questions around vaccine efficacy. Given that neither the structural information nor the experimentally-derived antibody interaction of this variant are available, we have turned to predictive computational methods to model the mutated structure of the spike protein's receptor binding domain and posit potential changes to vaccine efficacy. In this study, we predict some structural changes in the receptor-binding domain that may reduce antibody interaction without completely evading existing neutralizing antibodies (and therefore current vaccines).

  • Genomics, Distributed Computing, Data Engineering

    Genomics Data Lake eBook

    An eBook designed to help bioinformatics teams scale up their genomics research in the Azure cloud.

    Centralizing your data in a data lake has the potential to help scale and automate bioinformatics pipelines (including secondary and tertiary analyses and machine learning) in cloud. Azure Data Lake is touted as a limitless service place for storing your data. It provides the ability to store and organize petabyte-size files and connect to distributed computing resources (like Azure Databricks) with ease. In addition, Data Lake offers enterprise-grade security and role-based access controls.


    In this book, we discuss the utility of Azure Data Lake and how this flexible and scalable storage option promotes collaboration and scalability in your genomics practice while also ensuring a secure and stable environment for your genomics data. Plus, with its easy integration with other Azure services, orchestrating and automating data movements and bioinformatics pipelines has never been easier (or faster).

  • Genomics, Phylogenetics, Infectious Diseases

    P. falciparum CSP Haploytyping

    Modeling PfCSP haplotypes and their changes in protein interaction with human immunological proteins.

    The world's first malaria vaccine RTS,S provides only partial protection against Plasmodium falciparum infections. The explanation for such low efficacy is unclear. This study examined the associations of parasite genetic variations with binding affinity to human immunological proteins including human leukocyte antigen (HLA) and T cell receptors (TCR) involved in RTS,S-induced immune responses. Multiplicity of infections was determined by amplicon deep sequencing of merozoite surface protein 1 (PfMSP1). Genetic variations in the C-terminal of circumsporozoite protein (PfMSP1) gene were examined across 88 samples of P. falciparum collected from high and low transmission settings of Ghana. Binding interactions of PfMSP1 variants and HLA/TCR were analyzed using NetChop} and HADDOCK predictions. Anti-CSP IgG levels were measured by ELISA in a subset of 10 samples. High polyclonality was detected among P. falciparum infections. A total 27 CSP haplotypes were detected among samples. A significant correlation was detected between the CSP and MSP multiplicity of infection (MOI). No clear clustering of haplotypes was observed by geographic regions. The number of genetic differences in PfCSP between 3D7 and non-3D7 variants does not influence binding interactions to HLA/T cells nor anti-CSP IgG levels. Nevertheless, PfCSP peptide length significantly affects its molecular weight and binding affinity to the HLA. The presence of multiple non-3D7 strains among P. falciparum infections in Ghana impact the effectiveness of RTS,S. Longer PfCSP peptides may elicit a stronger immune response and should be considered in future version RTS,S. The molecular mechanisms of RTS,S cell-mediated immune responses related to longer CSP peptides warrants further investigations.

  • Genomics, Infectious Diseases, Bioinformatics

    SARS-CoV-2 Variant Tracking

    Building a visual dashboard for cataloging SARS-CoV-2 variants geographically.

    Several new variants of the SARS-CoV-2 have been isolated in the United States, Mexico, and Canada. Many of the variants contain single variants of functional significance (e.g. S: N501Y increases transmissibility). To study the occurrence and co-circulation of these variants, we have developed an easy-to-use dashboard.

  • Machine Learning, Distributed Computing, Data Engineering

    Sparkitecture

    A collection of "cookbook-style" scripts for simplifying data engineering and machine learning in Apache Spark.

    Apache Spark is a highly-scalable, massively-parallel computing platform perfect for machine learning and data engineering tasks. Using distributed processing with the Spark API, users can perform various tasks on huge amounts of data using their their preferred language (Python, R, Scala, SQL, etc.), but often there is a bit of a learning curve to using the Spark functionality (PySpark or SparkR) even if the user is a pro at the base language. Sparkitecture is a ebook collection of various script to help make this process a little easier.

  • Genomics, Machine Learning, Infectious Diseases

    Machine Learning in Malaria

    Machine Learning Modeling in the Prediction of Artemisinin Resistance and Diagnostic Test Sensitivity in Malaria.

    Parallel Processing and Ensemble Machine Learning Modeling for the Prediction of Artemisinin Resistance in Malaria (Malaria DREAM Challenge 2019 Submission).

    The Malaria DREAM Challenge is open to anyone interested in contributing to the development of computational models that address important problems in advancing the fight against malaria. The overall goal of the first Malaria DREAM Challenge is to predict Artemisinin (Art) drug resistance level of a test set of malaria parasites using their in vitro transcription data and a training set consisting of published in vivo and unpublished in vitro transcriptomes. The in vivo dataset consists of ~1000 transcription samples from various geographic locations covering a wide range of life cycles and resistance levels, with other accompanying data such as patient age, geographic location, Art combination therapy used, etc. [Mok et al., (2015) Science]. The in vitro transcription dataset consists of 55 isolates, with transcription collected at two timepoints (6 and 24 hours post-invasion), in the absence or presence of an Art perturbation, for two biological replicates using a custom microarray at the Ferdig lab. Using these transcription datasets, participants will be asked to predict three different resistance states of a subset of the 55 in vitro isolate samples.



    Modeling Plasmodium falciparum Diagnostic Test Sensitivity using Machine Learning with Histidine-Rich Protein 2 Variants.

    Malaria, predominantly caused by Plasmodium falciparum, poses one of largest and most durable health threats in the world. Previously, simplistic regression-based models have been created to characterize malaria infections, though these models often only include a couple genetic factors. Specifically, the Baker et al., 2005 model uses two types of particular repeats in histidine-rich protein 2 (PfHRP2) to assert P. falciparum infection, though the efficacy of this model has waned over recent years due to genetic mutations in the parasite. In this work, we use a dataset of 406 P. falciparum PfHRP2 genetic sequences collected in Ethiopia and derived a larger set of motif repeat matches for use in generating a series of diagnostic machine learning models. Here we show that the usage of additional and different motif repeats proves effective in predicting infection. Furthermore, we use machine learning model explanability methods to highlight which of the repeat types are most important, thereby suggesting potential targets for future versions of rapid diagnostic tests.

  • Genomics, Phylogenetics, Infectious Diseases

    StrainHub

    Shiny web application for visualizing disease transmittion networks from phylogenetic trees.

    Strainhub is designed as a web-based software to generate disease transmission networks and associated metrics from a combination of a phylogenetic tree and a metadata associated file. The software maps the metadata onto the tree and performs a parsimony ancestry reconstruction step to create links between the associated metadata and enable the construction of the network.

  • Genomics, Infectious Diseases

    Genetic Capitalism in E. coli

    Persistence of Genes that Confer Antimicrobial Resistance in the History of Escherichia coli Genomes

    Antimicrobial resistance (AMR) in pathogenic strains of bacteria, such as Escherichia coli (E. coli), adversely impact personal and public health. In this study, we examine competing hypotheses for the evolution of AMR including: 1) "genetic capitalism" in which genotypes that confer antibiotic resistance are gained and not often lost in lineages, and 2) "stabilizing selection" in which genotypes that confer antibiotic resistance are gained and lost often. To test these hypotheses, we assembled a dataset that includes annotations for 409 AMR genotypes and a phylogenetic tree based on genome-wide single nucleotide polymorphisms from 29,255 isolates of E. coli. We used phylogenetic methods to count the times each AMR genotype was gained and lost across the tree and used model-based clustering of the genotypes with respect to their gain and loss rates. We demonstrate that many genotypes cluster to support the hypothesis for genetic capitalism while a few cluster to support the hypothesis for stabilizing selection. Comparing the sets of genotypes that fall under each of the hypotheses, we found a statistically significant difference in the breakdown of resistance mechanisms through which the AMR genotypes function. The result that many AMR genotypes cluster under genetic capitalism reflects that strong positive selective forces, primarily induced by human industrialization of antibiotics, outweigh the potential fitness costs to the bacterial lineages for carrying the AMR genotypes. We expect genetic capitalism to further drive bacterial lineages to resist antibiotics. We find that antibiotics that function via replacement and efflux tend to behave under stabilizing selection and thus may be valuable in an antibiotic cycling strategy.

  • R Package, Genomics

    msgen

    R functions for interfacing with the Microsoft Genomics service in Azure.

    The Microsoft Genomics service in Azure can power genome sequencing using a cloud implementation of the Burrows-Wheeler Aligner (BWA) and the Genome Analysis Toolkit (GATK) for secondary analysis. The pipeline can take in multiple FASTQ and BAM files and provides alignment and variant outputs. The msgen package provides an interface to use the service from within R.

  • Human Genomics, Phylogenetics

    An Integrated Phylogeographic Analysis of the Bantu Migration

    Using phylogenetic analysis, dimensionality reduction, and machine learning, a combined migratory model of the Bantu migration was formed with heterogeneous data.

  • R Package, Genomics

    parEBEN

    Parallel Implementations of the Empirical Bayesian Elastic Net Cross-Validation in R.

    The Empirical Bayesian Elastic Net (EBEN) algorithm was developed by Huang et al. for handling multicollinearity in generalized linear regression models. Historically, this has been used in the analysis of quantitative trait loci (QTLs) and gene-gene interactions (epistasis). In addition to the algorithm, the group also created the EBEN package for R. This package includes functions to generate the elastic nets for both binomial and gaussian priors. These functions are efficient and do not require large amounts of computational time. However, the package also includes functions for the cross-validation of those models. While essential, this step is a considerably more complex task. The cross-validation functions perform a sweep to determine hyperparameters and minimize prediction error. More specifically, an n-fold cross-validation sweep is performed to minimize error by trying combinations of two parameters (α and λ) in a stepped manner. Experimentally, it has been shown that this can take a rather extended amount of time, especially on larger datasets (as seen in genomics problems).

  • Human Genomics, Phylogenetics, Linguistics

    Visualizing Linguistic Disparity of Uto-Aztecan Languages and Bantu Languages

    Using unsupervised learning for dimensionality reduction and visualization.

  • Phylogenetics, Epidemiology, Infectious Diseases

    Spread of Middle East Respiratory Coronavirus: Genetic versus Epidemiological Data

    Analysis and visualzation of the WHO reports of MERS infections versus genomic data.

  • Human Genomics, Machine Learning

    MPS-IIIB/NAGLU Prediction

    PolyPhen2 + Machine Learning prediction of the effects of genetic mutations on mucopolysaccharidosis IIIB.

04

Let's Connect!

Want to collaborate, connect, or a consult? Let's chat and see how we can work together to do awesome things...

Back To Top